Sat.Oct 03, 2020 - Fri.Oct 09, 2020

article thumbnail

Excel spreadsheet blamed for UK’s COVID-19 test and trace woes

pharmaphorum

An Excel spreadsheet was behind IT glitch that caused thousands of positive COVID-19 tests to be omitted from the UK’s official records, according to press reports. The issue that left almost 16,000 positive results going unreported has been blamed on the way Public Health England tracks results from mainly private labs that have been hired to add extra testing capacity.

Hospitals 128
article thumbnail

Clinical trials have ‘much work to do’ in boosting diversity

Outsourcing Pharma

A veteran with more than 20 years of experience talks about the vitality of recruiting an inclusive patient population, and the perils of falling short.

131
131
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Lansoprazole vs Omeprazole: differences and similarities

Druggist

In today’s post, I will contrast the two most popular proton pump inhibitors (PPIs) prescribed in the UK. Not only lansoprazole and omeprazole are the two most common PPI, but they are also one of the most popular prescribed drugs in the UK. I will review the essential facts to highlight the similarity and difference between each medication. Lansoprazole vs omeprazole – post summary: Lansoprazole vs omeprazole: drug classification Lansoprazole vs omeprazole: mechanism of action Lansoprazol

article thumbnail

Perspectives on a Post-pandemic World

Pharma Marketing Network

An interview with Mark Bard, Co-Founder of The DHC Group and Justin Grossman, CEO/Managing Partner, meltmedia. In response to this week’s DHC Virtual Summit with Novartis, Mark Bard, Co-founder/Managing Partner, DHC, talked one-on-one with Justin Grossman about how the COVID pandemic will change the world of digital healthcare marketing. Here are some highlights from their discussion.

article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Your.MD secures $30m to expand self-care app Healthily

pharmaphorum

Digital health firm Your.MD has secured $30 million in a Series A round investment led by the consumer health giant Reckitt Benckiser (RB). Your.MD is the company behind the medical-grade, augmented intelligence self-care app Healthily, and will use the funding to accelerate the platform through a series of clinically-validated “health hubs”. Following a seed funding round led by RB and existing shareholders, the now completed Series A funding round will allow the app to reach other markets incl

124
124
article thumbnail

People on the Move: October 2020

Outsourcing Pharma

The latest news on pharmaceutical industry hires, promotions, acquititions and other events includes Medable, Eversana, Parexel, Astellas and more.

98

More Trending

article thumbnail

Perspectives on a Post-pandemic World

Pharma Marketing Network

An interview with Mark Bard, Co-Founder of The DHC Group and Justin Grossman, CEO/Managing Partner, meltmedia. In response to this week’s DHC Virtual Summit with Novartis, Mark Bard, Co-founder/Managing Partner, DHC, talked one-on-one with Justin Grossman about how the COVID pandemic will change the world of digital healthcare marketing. Here are some highlights from their discussion.

article thumbnail

Eli Lilly and Gilead’s combination cuts COVID-19 recovery time

pharmaphorum

Eli Lilly’s Olumiant (baricitinib) has a significant effect on recovery from COVID-19 when combined with Gilead Veklury (remdesivir), according to a large trial backed by funding from the US government. The findings came from additional safety and efficacy data harvested from the US National Institute of Allergy and Infectious Diseases’ (NIAID) ACCT-2 trial.

article thumbnail

Premier Research: holistic approach benefits drug development

Outsourcing Pharma

A leader from the CRO shares insights as to what strategies and philosophies work best when working to craft a successful drug development program.

98
article thumbnail

Romaco implements new sustainability strategy

Pharma Mirror

Romaco has appointed a Sustainability Officer and defined goals for the company’s climate-friendly development. Not only is the manufacturer seeking to enable more sustainable production by its customers; Romaco is also keen to improve its own carbon footprint. The Romaco Group has a new central corporate objective: sustainability. To enable climate protection measures to be.

52
article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Maintaining Both Your Business and Your Sanity During the Pandemic

Pharma Marketing Network

Just a little more than seven months ago, pharma, agencies, vendors, physicians, pharmacists, patients, and medical supply chains in the U.S. and across the world were caught in a whirlwind of groundlessness and anxiety as Covid -19’s spread quickly enveloped much of the planet. Such a shock to the system required a lot of intense, focused learning to keep the industry up and running, to keep all of healthcare’s stakeholders connected, to continue the mission to safeguard and preserve health.

article thumbnail

Pharma’s response to COVID: GSK

pharmaphorum

A few months into the pandemic, the world is now moving beyond managing the crisis, with more focus on addressing the collateral damages and shaping the future. As part of a new series looking at how pharma has responded to the pandemic, Neale Belson, SVP UK & Ireland and general manager for the UK at GSK, tells us that it is “absolutely critical” to do this with the pace and out-of-the box thinking of the past months.

Vaccines 111
article thumbnail

Clinical trial volume, variety drive data solutions

Outsourcing Pharma

eClinical, a provider of clinical data service solutions, has seen an increase in interest in clinical data platform and other digital products.

80
article thumbnail

Biocartis Announces Market Release of SeptiCyte® RAPID test on Idylla™

Pharma Mirror

Biocartis Group NV (the ‘Company’ or ‘Biocartis’), an innovative molecular diagnostics company (Euronext Brussels: BCART), today announces the market release of SeptiCyte® RAPID on Idylla™ as a CE-marked IVD test. SeptiCyte® RAPID is a host-response test that distinguishes sepsis from non-infectious systemic inflammation in patients suspected of sepsis and provides actionable results in about one.

52
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

article thumbnail

Maintaining Both Your Business and Your Sanity During the Pandemic

Pharma Marketing Network

Just a little more than seven months ago, pharma, agencies, vendors, physicians, pharmacists, patients, and medical supply chains in the U.S. and across the world were caught in a whirlwind of groundlessness and anxiety as Covid -19’s spread quickly enveloped much of the planet. Such a shock to the system required a lot of intense, focused learning to keep the industry up and running, to keep all of healthcare’s stakeholders connected, to continue the mission to safeguard and preserve health.

article thumbnail

Flying the flag for research in Aarskog syndrome

pharmaphorum

Delayed diagnosis, lack of awareness, and a limited evidence base – Aarskog syndrome faces all the challenges of rare diseases everywhere. But a new study hopes to kick start a revolution in understanding. For five years, Michelle Erskine faced a succession of closed doors and disbelief as she struggled to convince someone that all was not well with her son.

111
111
article thumbnail

Investors bet on decentralized trial technology

Outsourcing Pharma

Companies like Biofourmis, THREAD and other virtual tech specialists have seen infusions of funds from investors bullish on decentralized clinical trials.

72
article thumbnail

Full CPhI & Pharmapack Europe schedule returns in 2021 with live & hybrid events

Pharma Mirror

Informa Markets announces its complete listing of pharma event dates for 2021 at the opening of the first CPhI Festival of Pharma (05 – 16 October 2020) – the largest ever virtual pharma event. The pharma schedule includes one further event in 2020: CPhI China, 16-18 December (hybrid event, combining “live” in-person with “virtual”). In. The post Full CPhI & Pharmapack Europe schedule returns in 2021 with live & hybrid events appeared first on Pharma Mirror Magazine.

52
article thumbnail

Ep. 008 – Vlad Mkrtumyan Podcast Transcript

Pharma Marketing Network

Don ( PMN): Hello everyone thanks for joining us at the Pharma marketing podcast. I’m your host Don Langsdorf our guest today is Vlad Mkrtumyan. He’s a serial entrepreneur, a search engine marketing evangelist and a passionate networker. He’s also responsible for running 5 meet ups including the Seattle Marketing in demand leaders meet up which is the largest marketing meet up in Seattle.

article thumbnail

Older people first to receive COVID-19 vaccine in UK, says government

pharmaphorum

As European regulators begin a rolling review of AstraZeneca’s COVID-19 vaccine, the focus in the UK has shifted to the government’s plans to distribute any vaccine that is deemed to be a safe and effective way of preventing the disease. According to weekend press reports a rollout of a vaccine could be just three months away – but the feedback from the government is that not everyone will get it, with the target group being around 30 million older people and health workers, less than half the p

Vaccines 111
article thumbnail

First patient dosed in long-term Alzheimer’s trial

Outsourcing Pharma

Neurotrope has kicked off its ongoing Phase II study of Bryostatin-1 for treatment of Alzheimerâs disease, with the help of a $2.7m NIH grant.

60
article thumbnail

Zinc Drug Interactions

Med Ed 101

I’m seeing, reading, and hearing a lot about zinc in the prevention and management of various infectious diseases such as COVID and head colds. While I’m not very sold on the data supporting its use, there will be patients that are going to try it. It is critical to remember that if you have patients […]. The post Zinc Drug Interactions appeared first on Med Ed 101.

40
article thumbnail

ABPI calls on UK government to create non-COVID clinical research strategy

Pharma Times

New report finds UK is leading on early-stage clinical trials but needs strategy to restart non-COVID research

48
article thumbnail

EU ramps up supply of COVID-19 vaccine, drugs

pharmaphorum

The European Commission has taken its advance orders for potential COVID-19 vaccines to more than 1.1 billion, after signing a supply deal for up to 400 million doses of Johnson & Johnson’s experimental candidate. The agreement is the third for coronavirus vaccine supply for the EU, coming after earlier deals with AstraZeneca and Sanofi/GlaxoSmithKline, and comes as wealthy nations are scrambling to secure access to the initial supplies of the shots furthest ahead in development.

Vaccines 105
article thumbnail

FDA COVID-19 response roundup

Outsourcing Pharma

As the pandemic maintains its hold, the US agency continues to issue advice and take action related to testing, treatment and information on the virus.

FDA 52
article thumbnail

Rybelsus With Food. Is This Ok?

Med Ed 101

I was asked this question the other day and I wanted to specifically address it. What should I do if I didn’t take Rybelsus (semaglutide) 30 minutes before I ate because the package insert says I’m supposed to be taking Rybelsus with food? Rybelsus has very low systemic absorption in comparison to injectable semaglutide (Ozempic). […].

article thumbnail

BMS’ Opdivo plus Yervoy misses the mark in high-risk melanoma

Pharma Times

Combination treatment did not achieve statistical significance in all-comer population

51
article thumbnail

CRISPR pioneers Doudna and Charpentier claim Nobel chemistry prize

pharmaphorum

Drs Emmanuelle Charpentier and Jennifer Doudna have won this year’s Nobel Prize for chemistry in recognition of their work on the gene-editing technology CRISPR/Cas9. Charpentier – currently at the Max Planck Unit for the Science of Pathogens in Germany – and Doudna of the University of California, Berkeley (pictured left to right), are the first two women to share the prize awarded by the Royal Swedish Academy of Sciences.

105
105
article thumbnail

ATCC lands $250m from BARDA for COVID-19 services

Outsourcing Pharma

The contract, with a ceiling value of $250M and potential length of 10 years, will supplement the companyâs ongoing support of virus-related work.

52
article thumbnail

14 BEST IBS Medication Over The Counter

Druggist

Irritable bowel syndrome (IBS) is a common condition which is characterised by smooth muscle spasm alongside the gastrointestinal tract with a range of associated symptoms. Patients who are diagnosed with IBS are usually advised on the lifestyles to minimise the risk of IBS symptoms. Review of diet and lifestyle is one of the first recommendations gives by a doctor once a patient is diagnosed with IBS.

98
article thumbnail

ViiV’s two-drug HIV regimen demonstrates long-term efficacy

Pharma Times

Two-drug regimen continues to offer non-inferior efficacy compared to a three-drug regimen

48
article thumbnail

Lilly asks FDA for emergency clearance for COVID-19 antibody therapy

pharmaphorum

Eli Lilly has asked the FDA for an Emergency Use Authorization for its COVID-19 antibody therapy, after announcing new efficacy data from an ongoing trial. It’s been a big week for this class of therapies – Regeneron’s antibody cocktail was famously used to treat president Donald Trump’s illness and GlaxoSmithKline is expanding research into its rival.

FDA 98
article thumbnail

CPhI, Pharmapack Europe to return in 2021

Outsourcing Pharma

The popular pharma industry conferences plan to combine live and digital elements when assembling its calendar of international events next year.

52
article thumbnail

What Has Traveling Solo Meant for me?

Colors Make me Happy

“You must be brave!” These are some of the words I am told regularly followed by an awed look. My addiction to traveling began with my first adventure, where I quickly learned to love the world. It all started when I made travel plans with a group of classmates in graduate school for a month getaway in Italy and Egypt. Everyone flaked out of the plan as we got closer to the travel dates and I was forced to embark on the journey alone.

52